← Open Payments lookup

KELLIE GROVE: Open Payments

NPI 1811472681 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,226 in 164 payments from 26 companies in 2025. Trend: 2023 $1,615 · 2024 $2,568 · 2025 $3,226

Food & beverage: $3,215Education: $11
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP28$646
GlaxoSmithKline, LLC.36$479
Merck Sharp & Dohme LLC12$243
GENZYME CORPORATION8$204
HARMONY BIOSCIENCES LLC7$200
Boehringer Ingelheim Pharmaceuticals, Inc.11$193
Regeneron Healthcare Solutions, Inc.8$179
JAZZ PHARMACEUTICALS INC.6$143
Electromed, Inc.8$117
Grifols USA, LLC4$115

Products named: DUPIXENT, BREZTRI, FASENRA, NUCALA, TRELEGY ELLIPTA, WAKIX, XYWAV, ZERBAXA.

Industry payments across MS — which companies pay providers there.